Squarex, LLC

11:15 AM - 11:30 AM, Thursday, June 6, 2019 ・ Theater 4
Squarex is developing a topical drug for the PREVENTION of cold sores -- herpes labialis or oral herpes outbreaks -- in persons with frequent cold sores. Completed clinical trials show one topical dose to the arm (not the lip) significantly boosts immune response and significantly prevents outbreaks for 3 months.
Ticker:
Not Provided.
Exchange:
Not Provided.
Company Type:
Company Website:
Company HQ State:
Minnesota
Company HQ Country:
United States
Year Founded:
2012
Main Therapeutic Focus:
Lead Product in Development:
SQX770
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
1
Speaker
photo
President
Squarex, LLC